Kaleido Biosciences, Inc. (KLDO): Price and Financial Metrics


Kaleido Biosciences, Inc. (KLDO)

Today's Latest Price: $7.80 USD

0.20 (2.63%)

Updated Jul 2 4:00pm

Add KLDO to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

KLDO Daily Price Range
KLDO 52-Week Price Range

KLDO Stock Price Chart Technical Analysis Charts


KLDO Price/Volume Stats

Current price $7.80 52-week high $10.36
Prev. close $7.60 52-week low $2.82
Day low $7.55 Volume 114,755
Day high $7.98 Avg. volume 157,802
50-day MA $7.00 Dividend yield N/A
200-day MA $6.63 Market Cap 237.85M

Kaleido Biosciences, Inc. (KLDO) Company Bio


Kaleido Biosciences, Inc. is a healthcare company, which focuses on leveraging the potential of the microbiome organ to treat disease and improve human health. The company was founded by Geoffrey von Maltzahn and Noubar B. Afeyan in 2015 and is headquartered in Lexington, MA.


KLDO Latest News Stream


Event/TimeNews Detail
Loading, please wait...

KLDO Latest Social Stream


Loading social stream, please wait...

View Full KLDO Social Stream

Latest KLDO News From Around the Web

Below are the latest news stories about Kaleido Biosciences Inc that investors may wish to consider to help them evaluate KLDO as an investment opportunity.

Kaleido Biosciences announces CEO leadership transition

Kaleido Biosciences (KLDO) announced Alison Lawton to step down as President and CEO to attend to a family health matter. Ms. Lawton will continue to serve as a Director and special advisor to Kaleido and will support the company through this transition.The Board of Directors has established an Office of the CEO...

Seeking Alpha | June 16, 2020

Kaleido Biosciences Announces CEO Leadership Transition

Kaleido Biosciences, Inc. (KLDO), a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced that Alison Lawton has chosen to step down from her position as President and Chief Executive Officer in order to return to the United Kingdom and attend to an unexpected family health matter. Ms. Lawton will continue to serve as a Director and special advisor to Kaleido and will support the company through this transition.

Yahoo | June 16, 2020

Kaleido Biosciences Announces 2020 Annual Meeting of Stockholders to be Held as Virtual Meeting

Kaleido Biosciences, Inc. (KLDO), a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced that in light of the COVID-19 pandemic, its 2020 Annual Meeting of Stockholders will now be held solely by live webcast to comply with public health recommendations and protect the health of employees, Stockholders and directors. Stockholders will no longer be able to attend the Annual Meeting in person. There are no changes to the items of business to be addressed at the Annual Meeting, which are described in Kaleido’s proxy materials that were distributed previously and are available at www.proxydocs.com/KLDO.

Yahoo | June 8, 2020

Theodose Melas-Kyriazi Is The Independent Director of Kaleido Biosciences, Inc. (NASDAQ:KLDO) And Just Spent US$250k On Shares

Investors who take an interest in Kaleido Biosciences, Inc. (NASDAQ:KLDO) should definitely note that the Independent...

Yahoo | June 7, 2020

Kaleido Biosciences to Present During the Goldman Sachs 41st Annual Global Healthcare Conference

LEXINGTON, Mass., June 04, 2020 -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to.

Yahoo | June 4, 2020

Read More 'KLDO' Stories Here

KLDO Price Returns

1-mo 10.64%
3-mo 40.79%
6-mo 34.48%
1-year -14.10%
3-year N/A
5-year N/A
YTD 55.38%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7269 seconds.